Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons

Journal of Neurochemistry

Volumn 106, Issue 6, 2008, Pages 2410-2420

  Higuchi, Megumi ^a   Suzuki, Yuichi ^a   Yatani, Yumi ^a   Kitagawa, Yutaka ^a   Nagayasu, Kazuki ^a   Shirakawa, Hisashi ^a   Nakagawa, Takayuki ^a   Kaneko, Shuji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

3,4 Methylenedioxymethamphetamine; Drug addiction; Mesencephalic slice culture; Methamphetamine; Sensitization; Serotonergic neurons

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CITALOPRAM; DIZOCILPINE; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN; TRITIUM; TRYPTOPHAN HYDROXYLASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAPHE NUCLEUS; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANIMALS, NEWBORN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; EXCITATORY AMINO ACID ANTAGONISTS; MESENCEPHALON; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; ORGAN CULTURE TECHNIQUES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN; SYNAPTIC TRANSMISSION; UP-REGULATION;

RATTUS;

EID: 51049109399     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05583.x     Document Type: Article

References (67)

1. Aghajanian G. K. Wang R. Y. (1977) Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res. 122, 229 242.
2. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51, 914 922.
3. Amargós-Bosch M., Adell A. Artigas F. (2007) Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. J. Neurochem. 102, 550 561.
4. Bakhit C. Gibb J. W. (1981) Methamphetamine-induced depression of tryptophan hydroxylase: recovery following acute treatment. Eur. J. Pharmacol. 76, 229 233.
5. Baumgarten H. G. Lachenmayer L. (2004) Serotonin neurotoxins - past and present. Neurotox. Res. 6, 589 614.
6. Blandina P., Goldfarb J., Craddock-Royal B. Green J. P. (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251, 803 809.
7. Bortolozzi A., Díaz-Mataix L., Scorza M. C., Celada P. Artigas F. (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J. Neurochem. 95, 1597 1607.
8. Branchereau P., Chapron J. Meyrand P. (2002) Descending 5-hydroxytryptamine raphe inputs repress the expression of serotonergic neurons and slow the maturation of inhibitory systems in mouse embryonic spinal cord. J. Neurosci. 22, 2598 2606.
9. Breese G. R., Knapp D. J. Moy S. S. (2002) Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci. Biobehav. Rev. 26, 441 455.
10. Breier J. M., Bankson M. G. Yamamoto B. K. (2006) L-Tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions. J. Neurosci. 26, 290 299.
11. Callaway C. W., Wing L. L. Geyer M. A. (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4- methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther. 254, 456 464.
12. Celada P., Puig M. V., Casanovas J. M., Guillazo G. Artigas F. (2001) Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci. 21, 9917 9929.
13. Cole J. C. Sumnall H. R. (2003) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci. Biobehav. Rev. 27, 199 217.
14. Cransac H., Cottet-Emard J. M., Pequignot J. M. Peyrin L. (1996) Monoamines (norepinephrine, dopamine, serotonin) in the rat medial vestibular nucleus: endogenous levels and turnover. J. Neural. Transm. 103, 391 401.
15. Dafters R. I. (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol. Behav. 58, 877 882.
16. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38, 1195 1205.
17. 1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J. Neurosci. 25, 10831 10843.
18. Gartside S. E., McQuade R. Sharp T. (1996) Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J. Pharmacol. Exp. Ther. 279, 277 283.
19. Gartside S. E., Cole A. J., Williams A. P., McQuade R. Judge S. J. (2007) AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei. Eur. J. Neurosci. 25, 3001 3008.
20. Groenewegen H. J. Uylings H. B. (2000) The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog. Brain Res. 126, 3 28.
21. Grönig M., Atalla A. Kuschinsky K. (2004) Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine. Naunyn Schmiedebergs Arch. Pharmacol. 369, 228 231.
22. Guthrie K. M., Tran A., Baratta J., Yu J. Robertson R. T. (2005) Patterns of afferent projections to the dentate gyrus studied in organotypic co-cultures. Dev. Brain Res. 157, 162 171.
23. Han D. D. Gu H. H. (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6, 6.
24. 2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology 178, 505 513.
25. Hervé D., Pickel V. M., Joh T. H. Beaudet A. (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435, 71 83.
26. Hilber B., Scholze P., Dorostkar M. M., Sandtner W., Holy M., Boehm S., Singer E. A. Sitte H. H. (2005) Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology 49, 811 819.
27. Howell L. L. Kimmel H. L. (2008) Monoamine transporters and psychostimulant addiction. Biochem. Pharmacol. 75, 196 217.
28. Hrometz S. L., Brown A. W., Nichols D. E. Sprague J. E. (2004) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B. Neurosci. Lett. 367, 56 59.
29. Imai H., Steindler D. A. Kitai S. T. (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243, 363 380.
30. Itzha Y., Anderson K. L. Ali S. F. (2004) Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity. Ann. N. Y. Acad. Sci. 1025, 119 128.
31. 3H]Substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Synapse 30, 97 106.
32. Jonakait G. M., Schotland S. Ni L. (1988) Development of serotonin, substance P and thyrotrophin-releasing hormone in mouse medullary raphe grown in organotypic tissue culture: developmental regulation by serotonin. Brain Res. 473, 336 343.
33. Karler R., Calder L. D., Chaudhry I. A. Turkanis S. A. (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45, 599 606.
34. Katayama T., Minami M., Nakamura M., Ito M., Katsuki H., Akaike A. Satoh M. (2002) Excitotoxic injury induces production of monocyte chemoattractant protein-1 in rat cortico-striatal slice cultures. Neurosci. Lett. 328, 277 280.
35. Kita T., Wagner G. C. Nakashima T. (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J. Pharmacol. Sci. 92, 178 195.
36. Kuribara H., Asami T., Ida I., Iijima Y. Tadokoro S. (1992) Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine. Psychopharmacology 108, 271 275.
37. Lanteri C., Salomon L., Torrens Y., Glowinski J. Tassin J. P. (2008) Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33, 1724 1734.
38. Lyles J. Cadet J. L. (2003) Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res. Rev. 42, 155 168.
39. Maeda T., Fukazawa Y., Shimizu N., Ozaki M., Yamamoto H. Kishioka S. (2004) Electrophysiological characteristic of corticoaccumbens synapses in rat mesolimbic system reconstructed using organotypic slice cultures. Brain Res. 1015, 34 40.
40. 2A antagonist. Behav. Brain Res. 73, 163 167.
41. 1A-receptors. Prog. Neurobiol. 81, 133 178.
42. Nestler E. J. (2005) Is there a common molecular pathway for addiction? Nat. Neurosci. 8, 1445 1449.
43. Ohmori T., Abekawa T., Muraki A. Koyama T. (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48, 587 591.
44. 1A autoreceptors. Brain Res. 783, 173 178.
45. Papp E. C., Heimrich B. Freund T. F. (1995) Development of the raphe-hippocampal projection in vitro. Neuroscience 69, 99 105.
46. Parsons L. H. Justice Jr. J. B. (1993a) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606, 195 199.
47. Parsons L. H. Justice Jr. J. B. (1993b) Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61, 1611 1619.
48. Paxinos G., Törk I., Teccot L. H. Valentino K. L. (1991) Atlas of the Developing Rat Brain. Academic Press, San Diego.
49. Phelix C. F. Broderick P. A. (1995) Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res. Bull. 37, 37 40.
50. Pifl C., Nagy G., Berényi S., Kattinger A., Reither H. Antus S. (2005) Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters. J. Pharmacol. Exp. Ther. 314, 346 354.
51. Prisco S., Pagannone S. Esposito E. (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271, 83 90.
52. 1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav. Pharmacol. 8, 699 706.
53. 1A receptors inhibits amphetamine sensitization in mice. Life Sci. 66, 1011 1019.
54. 1B receptors in the sensitization to amphetamine in mice. Eur. J. Pharmacol. 422, 91 99.
55. Robinson T. E. Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247 291.
56. Roche M., Commons K. G., Peoples A. Valentino R. J. (2003) Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 23, 970 977.
57. 2R) agonist modulates the behavioral and cellular response to (+)-3,4- methylenedioxymethamphetamine [(+)-MDMA]. Drug Alcohol Depend. 81, 117 127.
58. Salomon L., Lanteri C., Glowinski J. Tassin J. P. (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc. Natl Acad. Sci. USA 103, 7476 7481.
59. Schmidt C. J. Taylor V. L. (1987) Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol. 36, 4095 4102.
60. Schmidt C. J. Taylor V. L. (1988) Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur. J. Pharmacol. 156, 121 131.
61. Selken J. Nichols D. E. (2007) α1-Adrenergic receptors mediate the locomotor response to systemic administration of (±)-3,4- methylenedioxymethamphetamine (MDMA) in rats. Pharmacol. Biochem. Behav. 86, 622 630.
62. Spanos L. J. Yamamoto B. K. (1989) Acute and subchronic effects of methylenedioxymethamphetamine [±-MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol. Biochem. Behav. 32, 835 840.
63. Sprague J. E., Everman S. L. Nichols D. E. (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4- methylenedioxymethamphetamine. Neurotoxicology 19, 427 441.
64. Sprague J. E., Moze P., Caden D., Rusyniak D. E., Holmes C., Goldstein D. S. Mills E. M. (2005) Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. Crit. Care Med. 33, 1311 1316.
65. Vanderschuren L. J. Kalivas P. W. (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151, 99 120.
66. Wolf M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679 720.
67. Wolf M. E., White F. J. Hu X. T. (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14, 1735 1745.